FAKTOR OPTIONSSCHEIN - STRYKER CORP. Share Price

Certificat

DE000PD5SYK7

Delayed Deutsche Boerse AG 11:50:59 03/07/2024 am IST
4.27 EUR -2.06% Intraday chart for FAKTOR OPTIONSSCHEIN - STRYKER CORP.
Current month-7.63%
1 month-8.21%
Date Price Change
03/24/03 4.27 -2.06%
02/24/02 4.36 -2.90%
01/24/01 4.49 -4.87%
28/24/28 4.72 -0.84%
27/24/27 4.76 -0.63%

Delayed Quote Deutsche Boerse AG

Last update July 03, 2024 at 11:50 am IST

More quotes

Static data

Product typeProductos Exóticos
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PD5SYK
ISINDE000PD5SYK7
Date issued 21/01/2022
Strike 340.2 $
Maturity Unlimited
Parity 1 : 1
Emission price 10
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 12.52
Lowest since issue 1.34
Spread 0.14
Spread %3.13%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
334.3 USD
Average target price
372.7 USD
Spread / Average Target
+11.50%
Consensus